FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+15.18%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$67.9M
AUM Growth
+$67.9M
(-35%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-63.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
3
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
|
$32M |
| 2 |
Talphera
TLPH
|
$4.48M |
| 3 |
Xencor
XNCR
|
$3.6M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$2.91M |
| 5 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$227K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Karyopharm Therapeutics
KPTI
$61.7M
| $37.4M | 55.08% | 999,275 -77,849 | -7% | -$2.91M |
|
|
2
Xencor
XNCR
$580M
| $9.35M | 13.77% | 582,881 -224,475 | -28% | -$3.6M |
|
|
BDSI
3
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $8.07M | 11.88% | 671,092 -18,908 | -3% | -$227K |
|
|
OREX
4
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $7.48M | 11.02% | 1,235,000 | – | – |
|
|
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
| $3.43M | 5.04% | 500,000 | – | – |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.17M | 3.2% | 55,767 | – | – |
|
|
7
Talphera
TLPH
$11.1M
| – | – | -816,251 | Closed | -$4.48M |
|
|
AMBI
8
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| – | – | -2,079,569 | Closed | -$32M |
|